American Cutaneous Leishmaniasis unresponsive to antimonial drugs: Successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline

International Journal of Dermatology

Volumn 42, Issue 3, 2003, Pages 203-207

  Báfica, André ^a,b   Oliveira, Fabiano ^a,b   Freitas, Luiz A R ^a,b   Nascimento, Eliane G ^c   Barral, Aldina ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Centro de Referência em Doenças Endêmicas Pirajá da Silva   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; MALE; SKIN DEFECT; SKIN EXAMINATION; SKIN LEISHMANIASIS; SKIN ULCER; DRUG ANTAGONISM; DRUG COMBINATION; FEMALE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, ORAL; ANTIPROTOZOAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038546370     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01868.x     Document Type: Article

References (18)

1. Marsden PD, Sampaio RNR. Mucocutaneous leishmaniasis: a review of clinical aspects. An Soc Bras Med Trop 1975; 4: 309-316.
2. Costa JML, Cunha AK, Gama MEA, Saldanha ACR. Diffuse cutaneous leishmaniasis in Brazil: a review. An Bras Dermatol 1998; 73: 565-576.
3. Sampaio SAP, Castro RM, Dillon NL et al. Treatment of mucocutaneous (American) leishmaniasis with amphotericin B. report of 70 cases. Int J Dermatol 1971; 10: 179-181.
4. Silva TMC, Barral A, Pompeo MML et al. In situ inflammatory immune response in human tegumentary leishmaniasis: morphologic evidence for a pathogenic role of TNF-α. Mem Inst Oswaldo Cruz 1998; 93: 49-50.
5. 4a Albanese G, Giorgetti P, Santoagostinho L et al. Cutaneous leishmaniasis: treatment with itraconazole. Arch Dermatol 1989; 125: 1540-1542.
6. Blackwell JM. Tumor necrosis factor alpha and mucocutaneous leishmaniasis. Parasitol Today 1999; 15: 73-75.
7. Da-Cruz AM, de Oliveira MP, De Luca PM et al. Tumor necrosis factor-alpha in human american tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 1996; 91: 225-119.
8. Mirshahi S, Soria J, Mirshahi M et al. Expression of elastase and fibrin in venous leg ulcer biopsies: a pilot study of pentoxifylline versus placebo. J Cardiovasc Pharmacol 1995; 25: 101-105.
9. Aviado DM, Dettelbach HR. Pharmacology of pentoxifylline a hemorrheologic agent for the treatment of intermittent claudication. Angiology; 1984; 35: 407-417.
10. Doherty GM, Jensen JC, Alexander HR et al. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 1991; 110: 192-198.
11. Hoebe KH, Gonzalez-Ramon N, Nijmeijer SM et al. Differential effects of pentoxifylline on the hepatic inflammatory response in porcine liver cell cultures. Increase in inducible nitric oxide synthase expression. Biochem Pharmacol 2001; 61: 1137-1144.
12. Koff AB, Rosen T. Treatment of cutaneous leishmaniasis. J Am Ac Dermatol 1994; 31: 693-708.
13. Lessa H, Machado P, Lima F et al. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 2001; 65: 87-89.
14. Harris E, Kropp G, Belli A et al. Single-step multiplex PCR assay for characterization of new world Leishmania complexes. J Clin Microbiol 1989; 36: 1989-1995.
15. Mendonça SC, Coutinho SG, Amendoeira RR et al. Human american cutaneous leishmaniasis (Leishmania b. braziliensis) in Brazil: lymphoproliferative responses and influence of therapy. Clin Exp Immunol 1986 May; 64: 269-276.
16. WHO. Control of Leishmaniases- Report of a WHO Expert Committee, 1990.
17. Ribeiro de Jesus A, Almeida RP, Lessa H et al. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998; 31: 143-148.
18. Nery JA, Perisse AR, Sales AM et al. The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy. Indian J Lepr 2000; 72: 457-467.